HIV-associated upodystrophy syndrome: Assessment and management

被引：5

作者：

Bodasing, N ^{[1
]}

Fox, R ^{[1
]}

机构：

[1] Gartnavel Royal Hosp, Brownlee Ctr, Dept Infect, Glasgow G12 0YN, Lanark, Scotland

来源：

JOURNAL OF INFECTION | 2003年 / 46卷 / 02期

关键词：

D O I：

10.1053/jinf.2002.1103

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：87 / 93

页数：7

共 56 条

[1] Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes [J].

Arioglu, E ;

Duncan-Morin, J ;

Sebring, N ;

Rother, KI ;

Gottlieb, N ;

Lieberman, J ;

Herion, D ;

Kleiner, DE ;

Reynolds, J ;

Premkumar, A ;

Sumner, AE ;

Hoofnagle, J ;

Reitman, ML ;

Taylor, SI .

ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) :263-274

[2]

AUBRONOLIVIER C, 2001, 8 C CLIN ASP TREATM

[3] Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy [J].

Barreiro, P ;

Soriano, V ;

Blanco, F ;

Casimiro, C ;

de la Cruz, JJ ;

González-Lahoz, J .

AIDS, 2000, 14 (07) :807-812

[4]

BLANCO F, 2000, 2 INT WORKSH ADV DRU

[5]

BODASING N, 2002, HIV MED, V1, P184

[6]

BONNET E, 2000, 7 C RETR OPP INF JAN

[7] Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy [J].

Brinkman, K ;

Smeitink, JA ;

Romijn, JA ;

Reiss, P .

LANCET, 1999, 354 (9184) :1112-1115

[8] Management of hyperlactatemia: no need for routine lactate measurements [J].

Brinkman, K .

AIDS, 2001, 15 (06) :795-797

[9]

BURN P, 2000, 7 C RETR OPP INF JAN

[10]

CALMY A, 2001, ANTIVIR THER, V6, P32

← 1 2 3 4 5 6 →